Molecular determinants of thrombosis recurrence risk across venous thromboembolism subtypes

Abstract excerpt

ABSTRACT: Venous thromboembolism (VTE) is a frequent (annual incidence of 1-2 per 1000 individuals) and potentially life-threatening (case-fatality rate up to 10%) disease. VTE is associated with serious short-term and long-term complications, including a recurrence rate approaching 20% within 5 years. Anticoagulant therapy, the mainstay of VTE treatment, drastically reduces the risk of early VTE recurrence, but...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Blood Coagulation and Thrombosis Mechanisms
• Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema
• Share to Venous Thromboembolism Diagnosis and Management